Clinical Trial Update: Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two doses of Menactra with a single dose of Monovalent Meningococcal Group C vaccine given with routine immunizations; results posted af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Infection

Drugs mentioned

• Menactra (Meningococcal conjugate vaccine (A, C, W, Y))
• Monovalent Meningococcal Group C Vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcal Infection | Phase 3 | Status: COMPLETED | Results posted: 2013-05-24